Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - clavulanic acid; amoxicillin - powder for oral suspension - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 250 mg clavulanic acid 125 mg - antibacterials for systemic use

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - amoxicillin, clavulanic acid - film-coated tablet - amoxicillin 500 mg clavulanic acid 125 mg - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

brown & burk uk ltd - amoxicillin (as amoxicillin trihydrate); clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1)) - film-coated tablet - 875 mg/125 milligram(s) - penicillins with extended spectrum; amoxicillin

Ireland - English - HPRA (Health Products Regulatory Authority)

brown & burk uk ltd - amoxicillin (in the form of amoxicillin trihydrate); clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1)) - film-coated tablet - 250 mg/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

brown & burk uk ltd - amoxicillin (in the form of amoxicillin trihydrate); clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1)) - film-coated tablet - 500 mg/125 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sandoz gmbh - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension - 400mg/5ml+ 57mg/5ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - amoxicillin trihydrate - oral capsule - 250mg

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - clavulanic acid as potassium salt 11.4 mg/ml; amoxicillin as trihydrate 80 mg/ml - amoxicillin and enzyme inhibitor - augmentin is indicated for the treatment of the following infections in adults and children: • acute bacterial sinusitis (adequately diagnosed)• acute otitis media• acute exacerbations of chronic bronchitis (adequately diagnosed)• community acquired pneumonia• cystitis• pyelonephritis• skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• bone and joint infections, in particular osteomyelitis.• recurrent tonsillitis

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.